Merck
MRK
#41
Rank
S$477.72 B
Marketcap
S$193.63
Share price
2.39%
Change (1 day)
72.99%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): S$4.58

According to Merck's latest financial reports the company's current EPS (TTM) is S$4.54. In 2025 the company made an earnings per share (EPS) of S$9.28 an increase over its 2024 EPS that were of S$8.58.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.58-50.64%
2025S$9.288.15%
2024S$8.584308.46%
2023S$0.19-97.32%
2022S$7.2710.92%
2021S$6.5684.68%
2020S$3.55-27.2%
2019S$4.8863.44%
2018S$2.98151.11%
2017S$1.19-54.58%
2016S$2.6230.21%
2015S$2.01-61.99%
2014S$5.28180.51%
2013S$1.88-31.82%
2012S$2.766.62%
2011S$2.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.09 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$8.91 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.66-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.58 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$35.83 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.38 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$3.25-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$4.52-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.93 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$1.74-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel